1. Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial. Issue 7 (2nd July 2020) Authors: Su, Ying-Ying; Lin, Bi-Zhen; Zhao, Hui; Li, Juan; Lin, Zhi-Jie; Qiao, You-Lin; Wei, Li-Hui; Hu, Yue-Mei; Li, Rong-Cheng; Zhuang, Si-Jie; Sun, Guang; Zheng, Zi-Zheng; Huang, Shou-Jie; Wu, Ting; Zhang, Jun; Pan, Hui-Rong; Li, Chang-Gui Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 7(2020) Page Start: 1636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial. Issue 7 (2nd July 2020) Authors: Su, Ying-Ying; Lin, Bi-Zhen; Zhao, Hui; Li, Juan; Lin, Zhi-Jie; Qiao, You-Lin; Wei, Li-Hui; Hu, Yue-Mei; Li, Rong-Cheng; Zhuang, Si-Jie; Sun, Guang; Zheng, Zi-Zheng; Huang, Shou-Jie; Wu, Ting; Zhang, Jun; Pan, Hui-Rong; Li, Chang-Gui Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 7(2020) Page Start: 1636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial. Issue 6 (30th November 2022) Authors: Mo, Zhao-Jun; Bi, Zhao-Feng; Sheng, Wei; Chen, Qi; Huang, Teng; Li, Ming-Qiang; Cui, Xue-Lian; Wangjiang, Ya-Hui; Lin, Bi-Zhen; Zheng, Feng-Zhu; Sun, Guang; Li, Ya-Fei; Zheng, Ya; Zhuang, Si-Jie; Su, Ying-Ying; Pan, Hui-Rong; Huang, Shou-Jie; Wu, Ting; Zhang, Jun; Xia, Ning-Shao Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗